Patient with nr-axSpA taking CIMZIA

live in the present,not the pain

If inflammatory back pain is holding you back, it's time to move forward.

Introducing CIMZIA, the first and only therapy of its kind for adults with non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation.*

*CIMZIA is an anti-tumor necrosis factor (TNF) biologic.

In a clinical trial, nearly 5 out of 10 people taking CIMZIA had major improvement in disease activity at 52 weeks—for some in as fast as 2 weeks.†

†47% of CIMZIA patients at 52 weeks vs. 7% of placebo patients; 21% of CIMZIA patients at 2 weeks vs. 1% of placebo patients. Based on a tool that measures disease activity such as back pain, stiffness, and joint swelling. Patients were allowed to use additional medications for their nr-axSpA.

Reduced nr-axSpA Symptoms

Nearly 7 out of 10 patients who stayed on CIMZIA achieved low symptom activity or non-active disease at 52 weeks.

Disease activity was measured by different categories including very high disease, high disease, low disease, and non-active disease. At the start of the trial, 99% of patients had very high or high disease activity and at 52 weeks, 69.5% of CIMZIA patients achieved low disease activity or non-active disease. This only includes patients who continued on CIMZIA for the full year, in addition to current standard treatment. Individual results may vary. 

nr-axSpA: How CIMZIA® (certolizumab pegol) Could Work For You

Your Back Pain Is Different – Your Treatment Should Be Too

Ask your doctor about how CIMZIA treats the signs and symptoms of nr-axSpA.

It's time to get back to life, with fewer interruptions from the inflammatory back pain of nr-axSpA. It's time to learn about CIMZIA.

The CIMZIA doctor discussion guide is available for download to assist with your next conversation with your rheumatologist

How Disruptive Is Your Inflammatory Back Pain?

Let's take a look at how you're managing your symptoms. Whether or not evidence is present on x-ray, you may still be experiencing ongoing symptoms of inflammation caused by non-radiographic axial spondyloarthritis. Having an honest conversation with a rheumatologist about its impact may help uncover the right diagnosis for you.

Want important reminders and quick tips from CIMZIA?

Just check your inbox.